StonvexLoading…
StonvexStonvexStonvexCore line items from PTGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $46.02M | $434.43M | $60.00M | $26.58M |
Operating Income | $-158.13M | $252.84M | $-93.65M | $-131.37M |
Net Income | $-130.15M | $275.19M | $-78.95M | $-127.39M |
EPS (Diluted) | $-2.05 | $4.23 | $-1.39 | $-2.60 |
Total Assets | $668.19M | $744.73M | $357.95M | $247.93M |
Total Liabilities | $53.48M | $69.43M | $21.27M | $32.32M |
Cash & Equivalents | $128.39M | $97.25M | $186.73M | $125.74M |
Free Cash Flow OCF − CapEx | $56.08M | $182.80M | $-70.84M | $-108.93M |
Shares Outstanding | 62.58M | 61.04M | 57.71M | 49.34M |